Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer
/in Cervical Cancer, International Publications /von 2004-12-01 / Gynecol. Oncol. 2004 Dec;95(3):680-5Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer
/in International Publications, Prostate Cancer /von 2004-12-01 / J. Urol. 2004 Dec;172(6 Pt 2):2532-8Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-12-01 / J. Hepatol. 2004 Dec;41(6):999-1007Current approaches in ovarian cancer vaccines
/in International Publications, Ovarian Cancer /von 2004-12-01 / Minerva Ginecol 2004 Dec;56(6):515-27Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
/in HIV/AIDS, International Publications /von 2004-11-28 / Nat. Med. 2004 Dec;10(12):1359-65Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-11-01 / J. Immunother. 2004 Nov-Dec;27(6):452-9Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-62Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8022-8Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells
/in International Publications, Newcastle Disease Virus /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8057-61
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de